Delivery Order SPE2DB24D6038-SPE2DB25FEMNP
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On July 30, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,202.16 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in 60-gram units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 31, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $2,424.17 under a firm fixed-price contract type. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- This delivery order, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on August 5, 2025, provides $1,113.09 in firm fixed price funding for ZORYVE 0.3% Foam 60gm, a pharmaceutical product to be delivered to the Conshohocken, Pennsylvania location with completion targeted for August 6, 2025. The award represents a non-competitive delivery order issued under an existing contract vehicle, reflecting DLA's established relationship with AmerisourceBergen as a critical...
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for ZORYVE 0.15% Cream in a 60-gram size. This firm fixed-price delivery order, valued at $1,018.11, represents a competitive award with no set-aside designation and carries an ultimate completion date of July 29, 2025. The contract is executed under AmerisourceBergen's broader Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,983.94 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation,...
- The Defense Logistics Agency awarded a $2,749.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Cream in 60GM quantity on August 12, 2025, with completion targeted for August 13, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill...
- This is a $15,023.02 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60 gram tubes of Zoryve 0.3% foam, a prescription topical medication, with a completion date of June 16, 2025. This award is associated with Amerisourcebergen's large $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.83, is for the supply of the pharmaceutical product ZORYVE 0.3% FOAM 60GM. The contract has a firm fixed price pricing type and a period of performance through February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,625.67 to AmerisourceBergen Drug Corp for ZORYVE 0.15% Cream 60GM, a pharmaceutical product. This contract was competitively awarded with no set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 4, 2025. The place of performance is listed as Conshohocken, PA 19428, which aligns with AmerisourceBergen's corporate headquarters location. This delivery order operates as a child...